A4G (p.Ala4Gly) variant of NRXN1 (Neurexin-1)

A4G (p.Ala4Gly) in NRXN1 (Neurexin-1) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.

A4G (p.Ala4Gly) variant details